Navigating 340B Manufacturer Restrictions: Tools for Success

We will discuss:

Presented By:

Justin Rolling
VP of National Sales

Anthony Velasquez
Chief Product Officer

340B WEBINAR:

© 2023 PharmaForce. All rights reserved.

In this webinar we will cover the recent manufacturer restrictions in the 340B market, including the latest legal updates, new restrictions, and lessons learned that will help covered entities navigate this new landscape.

Current Landscape: the current state and most recent development of the 20+ manufacturers that have joined the group who removed 340B drug access for CEs

Process for Submission: review the process for submission with each step to avoid common pitfalls

340B ESP/Price Restoration: common post data submission challenges and steps CEs can take to not lose pricing once provided

Best in KLAS^®. Three years and counting.

We’re proud to report that compared to the four largest TPAs in 340B, PharmaForce emerged as the overall best 340B Third Party Administrator with “A” ratings in every category, including overall performance, Culture, Loyalty, Operations, Product, Relationship, and Value—scoring a 91/100.

Overall Impact: how to quickly analyze effect on CEs access and financials

Operational Challenges: unique challenges with wholesalers, gateways, and chain pharmacies that could lead to missed savings